US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ImageneBio, Inc.

5.00

-0.3400-6.37%

Volume:15.31K

Turnover:78.65K

Market Cap:56.76M

PE:-1.04

High:5.54

Open:5.48

Low:4.96

Close:5.34

52wk High:13.98

52wk Low:3.94

Shares:11.35M

Float Shares:5.85M

Volume Ratio:2.72

T/O Rate:0.26%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.8133

EPS(LYR):-9.6449

ROE:-82.68%

ROA:-43.06%

PB:0.40

PE(LYR):-0.52

Loading ...

Overview Company News Filings

ImageneBio Price Target Announced at $28.00/Share by HC Wainwright & Co.

Imagenebio Inc : H.c. Wainwright Initiates Coverage with Buy Rating; Price Target $28

THOMSON REUTERS

U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

American Tungsten Maps High-Grade Resource at Idaho IMA Mine

ImageneBio Grants 144,000 RSUs, 112,525 Stock Options to New Hires Under Inducement Plan

Analysts Offer Insights on Healthcare Companies: Insulet (PODD), ImageneBio (IMA) and InMode (INMD)

Imagenebio - to Offer up to $200 Mln of Common Stock, Preferred Stock, Debt Securities, Warrants - SEC Filing

THOMSON REUTERS

ImageneBio Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

ImageneBio Q2 EPS $(0.63) Beats $(1.05) Estimate

Benzinga Earnings

Press Release: ImageneBio Reports Second Quarter 2026 Financial Results

ImageneBio CFO Yanina Grant-Huerta Files Initial Beneficial Ownership Statement

Imagenebio Names Yanina Grant-huerta CFO

Imagenebio - Appoints Yanina Grant-huerta as Chief Financial Officer Effective July 20, 2026 - SEC Filing

THOMSON REUTERS

Imagenebio Principal Accounting Officer Robert B. Lally Sells USD 17,350 of Common Shares

Imagenebio Inc Expected to Post a Loss of 89 Cents a Share - Earnings Preview

ImageneBio appoints Matt Robbins as general counsel

Imagenebio Names Matt Robbins General Counsel

Imagenebio Appoints Matt Robbins as General Counsel

THOMSON REUTERS

Imagenebio SVP Finance and Operations Robert Lally Resigns Effective July 22

ImageneBio stockholders approve amended 2025 equity incentive plan at annual meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/IMA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMA\",,,,,undefined,":{"symbol":"IMA","market":"US","secType":"STK","nameCN":"ImageneBio, Inc.","latestPrice":5,"timestamp":1788193407761,"preClose":5.34,"halted":0,"volume":15313,"delay":0,"changeRate":-0.0636704119850187,"floatShares":5846500,"shares":11351500,"eps":-4.813334,"marketStatus":"Trading","change":-0.34,"latestTime":"08-31 12:25:53 EDT","open":5.48,"high":5.54,"low":4.96,"amount":78650.92154699999,"amplitude":0.108614,"askPrice":4.98,"askSize":113,"bidPrice":4.94,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-4.813334,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788206400000},"marketStatusCode":2,"adr":0,"listingDate":1616731200000,"exchange":"NASDAQ","adjPreClose":5.34,"postHourTrading":{"tag":"盘后","latestPrice":5.34,"preClose":5.34,"latestTime":"16:10 EDT","volume":6,"amount":31.98,"timestamp":1787947804781,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.723423},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMA\",,,,,undefined,":{"symbol":"IMA","floatShares":5846500,"roa":"-43.06%","roe":"-82.68%","lyrEps":-9.64492,"volumeRatio":2.723423,"shares":11351500,"dividePrice":0,"high":5.54,"amplitude":0.108614,"preClose":5.34,"low":4.96,"week52Low":3.94,"pbRate":"0.40","week52High":13.98,"institutionHeld":0,"latestPrice":5,"committee":-0.982456,"eps":-4.813334,"divideRate":0,"volume":15313,"delay":0,"ttmEps":-4.813334,"open":5.48,"prevYearClose":6.9,"prevWeekClose":5.34,"prevMonthClose":5.54,"prevQuarterClose":5.9,"fiveDayClose":5.62,"twentyDayClose":5.64,"sixtyDayClose":5.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"IMA","fiscalQuarterEnding":"2026/06","expectedEps":-0.9,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":-0.63},{"market":"US","date":"2026-05-07","symbol":"IMA","fiscalQuarterEnding":"2026/03","expectedEps":-0.7,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.95},{"date":"2026-03-10","symbol":"IMA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773129600000,"name":null,"time":"Pre-MKt","dateTimestamp":1773115200000,"actualEps":null},{"market":"US","date":"2025-11-12","symbol":"IMA","fiscalQuarterEnding":"2025/09","expectedEps":-1.47,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-2.91},{"market":"US","date":"2025-07-28","symbol":"IMA","defaultRemindTime":1753709400000,"type":"split","dateTimestamp":1753675200000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0,"sell":0,"strongSell":0.25,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1787371200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMA","date":"2026-08-28","current":-1.038781,"percent":0.992395,"low":-8.134224,"twenty":-4.130459,"median":-1.537818,"eighty":-1.286369,"high":-1.122224,"avg":-2.404457,"sd":1.772499,"marketCap":60503260},"quantilePoints":[{"date":"2025-08-15","current":-8.134224,"twenty":-8.112228,"median":-8.06823,"eighty":-8.016532,"marketCap":165376899},{"date":"2025-08-22","current":-7.269609,"twenty":-8.089126,"median":-7.938985,"eighty":-7.265478,"marketCap":157437913},{"date":"2025-08-29","current":-6.949498,"twenty":-8.071529,"median":-7.347055,"eighty":-7.207651,"marketCap":150505278},{"date":"2025-09-05","current":-4.362798,"twenty":-8.06823,"median":-7.269609,"eighty":-7.002161,"marketCap":94485111},{"date":"2025-09-12","current":-4.750028,"twenty":-7.913135,"median":-7.165056,"eighty":-4.777909,"marketCap":102871364},{"date":"2025-09-19","current":-4.311167,"twenty":-7.809737,"median":-7.03727,"eighty":-4.615789,"marketCap":93366944},{"date":"2025-09-26","current":-4.016872,"twenty":-7.532127,"median":-6.908193,"eighty":-4.311167,"marketCap":86993392},{"date":"2025-10-03","current":-4.460896,"twenty":-7.322272,"median":-4.750028,"eighty":-4.238884,"marketCap":96609628},{"date":"2025-10-10","current":-4.24921,"twenty":-7.284065,"median":-4.672583,"eighty":-4.255406,"marketCap":92025144},{"date":"2025-10-17","current":-3.918773,"twenty":-7.257217,"median":-4.460896,"eighty":-4.122198,"marketCap":84868875},{"date":"2025-10-24","current":-3.815512,"twenty":-7.248956,"median":-4.418301,"eighty":-4.002415,"marketCap":82632541},{"date":"2025-10-31","current":-4.336982,"twenty":-7.148276,"median":-4.396358,"eighty":-4.069535,"marketCap":93926028},{"date":"2025-11-07","current":-4.331819,"twenty":-7.057922,"median":-4.378287,"eighty":-4.107742,"marketCap":93814211},{"date":"2025-11-14","current":-4.300841,"twenty":-7.039335,"median":-4.362798,"eighty":-4.109807,"marketCap":93143311},{"date":"2025-11-21","current":-1.760672,"twenty":-6.984607,"median":-4.334401,"eighty":-3.978665,"marketCap":76154335},{"date":"2025-11-28","current":-1.69911,"twenty":-6.937107,"median":-4.311167,"eighty":-3.941491,"marketCap":73491596},{"date":"2025-12-05","current":-1.66956,"twenty":-6.910259,"median":-4.306004,"eighty":-3.874371,"marketCap":72213481},{"date":"2025-12-12","current":-1.593223,"twenty":-6.057319,"median":-4.275025,"eighty":-1.94191,"marketCap":68911685},{"date":"2025-12-19","current":-1.524274,"twenty":-4.777909,"median":-4.254373,"eighty":-1.770522,"marketCap":65929417},{"date":"2025-12-26","current":-1.44055,"twenty":-4.748995,"median":-4.244047,"eighty":-1.699602,"marketCap":62308092},{"date":"2026-01-02","current":-1.69911,"twenty":-4.744865,"median":-4.207906,"eighty":-1.69911,"marketCap":73491596},{"date":"2026-01-09","current":-1.686797,"twenty":-4.71905,"median":-4.130459,"eighty":-1.664635,"marketCap":72959048},{"date":"2026-01-16","current":-1.62031,"twenty":-4.626115,"median":-4.109807,"eighty":-1.664635,"marketCap":70083290},{"date":"2026-01-23","current":-1.740972,"twenty":-4.605462,"median":-4.016872,"eighty":-1.646413,"marketCap":75302258},{"date":"2026-01-30","current":-1.803765,"twenty":-4.550733,"median":-3.972986,"eighty":-1.66168,"marketCap":78018252},{"date":"2026-02-06","current":-1.726197,"twenty":-4.505299,"median":-3.939426,"eighty":-1.666605,"marketCap":74663201},{"date":"2026-02-13","current":-1.686797,"twenty":-4.492908,"median":-3.903284,"eighty":-1.667098,"marketCap":72959048},{"date":"2026-02-20","current":-1.64986,"twenty":-4.473288,"median":-3.838746,"eighty":-1.658725,"marketCap":71361405},{"date":"2026-02-27","current":-1.681872,"twenty":-4.451603,"median":-2.010613,"eighty":-1.64986,"marketCap":72746029},{"date":"2026-03-06","current":-1.487337,"twenty":-4.445407,"median":-1.864096,"eighty":-1.631638,"marketCap":64331774},{"date":"2026-03-13","current":-1.479416,"twenty":-4.442309,"median":-1.812384,"eighty":-1.610461,"marketCap":67090032},{"date":"2026-03-20","current":-1.403396,"twenty":-4.424754,"median":-1.804381,"eighty":-1.602088,"marketCap":63642621},{"date":"2026-03-27","current":-1.33187,"twenty":-4.403586,"median":-1.785297,"eighty":-1.581403,"marketCap":60398973},{"date":"2026-04-02","current":-1.245545,"twenty":-4.395325,"median":-1.760672,"eighty":-1.558256,"marketCap":56484224},{"date":"2026-04-10","current":-1.171552,"twenty":-4.381385,"median":-1.750822,"eighty":-1.52919,"marketCap":53128726},{"date":"2026-04-17","current":-1.425594,"twenty":-4.352472,"median":-1.745897,"eighty":-1.516394,"marketCap":64649271},{"date":"2026-04-24","current":-1.445326,"twenty":-4.336982,"median":-1.731122,"eighty":-1.485808,"marketCap":65544070},{"date":"2026-05-01","current":-1.484788,"twenty":-4.334917,"median":-1.726197,"eighty":-1.480666,"marketCap":67333669},{"date":"2026-05-08","current":-1.457658,"twenty":-4.323558,"median":-1.705266,"eighty":-1.466579,"marketCap":66103320},{"date":"2026-05-15","current":-1.336106,"twenty":-4.311167,"median":-1.701572,"eighty":-1.456178,"marketCap":66659658},{"date":"2026-05-22","current":-1.247936,"twenty":-4.311167,"median":-1.69911,"eighty":-1.439072,"marketCap":62260797},{"date":"2026-05-29","current":-1.339497,"twenty":-4.310134,"median":-1.692954,"eighty":-1.43694,"marketCap":66828845},{"date":"2026-06-05","current":-1.286369,"twenty":-4.304971,"median":-1.681872,"eighty":-1.425603,"marketCap":64178249},{"date":"2026-06-12","current":-1.290891,"twenty":-4.296711,"median":-1.668329,"eighty":-1.408576,"marketCap":64403832},{"date":"2026-06-18","current":-1.286369,"twenty":-4.280189,"median":-1.665866,"eighty":-1.395997,"marketCap":64178249},{"date":"2026-06-26","current":-1.342888,"twenty":-4.269862,"median":-1.654785,"eighty":-1.358713,"marketCap":66998032},{"date":"2026-07-02","current":-1.304455,"twenty":-4.261601,"median":-1.64986,"eighty":-1.356453,"marketCap":65080580},{"date":"2026-07-10","current":-1.333845,"twenty":-4.255406,"median":-1.631391,"eighty":-1.351931,"marketCap":66546867},{"date":"2026-07-17","current":-1.232111,"twenty":-4.250243,"median":-1.62031,"eighty":-1.342436,"marketCap":61471258},{"date":"2026-07-24","current":-1.25924,"twenty":-4.24508,"median":-1.610461,"eighty":-1.339497,"marketCap":62824754},{"date":"2026-07-31","current":-1.336106,"twenty":-4.237851,"median":-1.605536,"eighty":-1.336106,"marketCap":66659658},{"date":"2026-08-07","current":-1.209921,"twenty":-4.218232,"median":-1.593223,"eighty":-1.333055,"marketCap":63501501},{"date":"2026-08-14","current":-1.269588,"twenty":-4.161438,"median":-1.58091,"eighty":-1.311237,"marketCap":66633046},{"date":"2026-08-21","current":-1.213354,"twenty":-4.130459,"median":-1.568598,"eighty":-1.294674,"marketCap":63681668},{"date":"2026-08-28","current":-1.152794,"twenty":-4.130459,"median":-1.537818,"eighty":-1.286369,"marketCap":60503260}],"updateTime":1788193553909},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661264474","title":"ImageneBio Price Target Announced at $28.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264474","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264474?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:30","pubTimestamp":1787308200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMA/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661261110","title":"Imagenebio Inc : H.c. Wainwright Initiates Coverage with Buy Rating; Price Target $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2661261110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661261110?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:05","pubTimestamp":1787306709,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0A5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250734","title":"U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250734?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:26","pubTimestamp":1787297213,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC SolutionsAug 21 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, incl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL8N44I09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FIX","ADI","HL","GTLB","MU","AMP","COTY","EGGY","FTH","DOCS","FTAI","AMYY","CTEV","DISK","BAI","AVGO","IXN","MATW","ACEL","SMHX","IMA","MTSI","AAP","MCHP","BCAL","QBTS","PI","HCAT","HRZN","DE","MRVL","P","VEGI","INNV","BWMN","LEGR","ADSK","DV","EBS","APP","ABT","CHAT","LMB","AVGU","FERG","TRFK","LYTS","MBX","AMD","ECG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660289725","title":"American Tungsten Maps High-Grade Resource at Idaho IMA Mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2660289725","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660289725?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:39","pubTimestamp":1787225959,"startTime":"0","endTime":"0","summary":"The latest update is out from Demesne Resources Ltd. ( ($TSE:TUNG) ). American Tungsten Corp. has reported a new Mineral Resource Estimate for its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/american-tungsten-maps-high-grade-resource-at-idaho-ima-mine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/american-tungsten-maps-high-grade-resource-at-idaho-ima-mine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4107","IMA","BK4007","BK4117","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660432521","title":"ImageneBio Grants 144,000 RSUs, 112,525 Stock Options to New Hires Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660432521","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660432521?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:30","pubTimestamp":1786998629,"startTime":"0","endTime":"0","summary":"ImageneBio grants 144,000 RSUs, 112,525 stock options to new hires under inducement planImageneBio set new equity compensation terms via inducement awards dated Aug. 14, 2026 for four new hires, inclu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL2Tp1pl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BKPKM429.USD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","SG9999014039.USD","LU2210150020.SGD","BK4112","SG9999014005.SGD","BCDF","IMA","BK4585","NDAQ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657824575","title":"Analysts Offer Insights on Healthcare Companies: Insulet (PODD), ImageneBio (IMA) and InMode (INMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657824575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657824575?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:40","pubTimestamp":1785962407,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Insulet (PODD), ImageneBio (IMA) and InMode (INMD). Insulet (PODD...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-insulet-podd-imagenebio-ima-and-inmode-inmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-insulet-podd-imagenebio-ima-and-inmode-inmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4566","BK4588","LU2065171402.SGD","BK4581","IMA","LU2065170008.USD","LU2065169927.USD","LU0728928796.USD","LABU","LU2324357040.USD","PODD","XLV","LU1119994496.HKD","INMD","LU0128526141.USD","HCSG","LU2065171311.SGD","BK4585","BK4082","XBI","BK4551","BK4137","BK4007","LU1084165304.USD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657578179","title":"Imagenebio - to Offer up to $200 Mln of Common Stock, Preferred Stock, Debt Securities, Warrants - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2657578179","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657578179?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:24","pubTimestamp":1785961440,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4421LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657540774","title":"ImageneBio Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657540774","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657540774?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:54","pubTimestamp":1785938059,"startTime":"0","endTime":"0","summary":"ImageneBio Inc reports results for the quarter ended June 30 - Earnings SummaryImageneBio IncIMA.OQreported a quarterly adjusted loss of 63 cents per share for the quarter ended June 30, higher than t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N44228V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657454484","title":"ImageneBio Q2 EPS $(0.63) Beats $(1.05) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657454484","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657454484?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:06","pubTimestamp":1785931576,"startTime":"0","endTime":"0","summary":"ImageneBio (NASDAQ:IMA) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(1.05) by 40 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60945840/imagenebio-q2-eps-0-63-beats-1-05-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSQ","QQQ","SQQQ","TQQY","TQQQ","NQmain","QDTE","NVIW.SI","QYLG","JEPQ",".IXIC","QLD","NDX","QQQM","GPIQ","QQQY","QQQE","BK4007","TECS","FTEC","QID","IYW","ONEQ","QQQJ","QQQA","MNQmain","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657544834","title":"Press Release: ImageneBio Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657544834","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657544834?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:00","pubTimestamp":1785931200,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Aug. 05, 2026  -- ImageneBio, Inc.   today reported financial results for the quarter ended June 30, 2026, and provided a company update.Company Highlights-- Olevaprubart, also known as IMG-007, the potential first-in-class. therapeutic targeting the OX40 pathway, is a non-T cell-depleting,ADCC-silenced, anti-OX40 receptor antagonist with an extended half-life.-- The Phase 2b ADAPTIVE trial of olevaprubart in moderate-to-severe. atopic dermatitis continues to progress as planned under the. -- A long-term extension  study has been opened for patients. enrolled in ADAPTIVE and sites are actively enrolling patients. -- A Phase 2 clinical trial of olevaprubart in alopecia areata is. -- The company will present two posters on olevaprubart at the 2026. -- Imagene strengthened its leadership team with the appointments of Yanina. Grant-Huerta as Chief Financial Officer and Matt Robbins as General. -- In July 2026, Imagene appointed Yanina Grant-Huerta as Chief Financial. -- She most","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655643880","title":"ImageneBio CFO Yanina Grant-Huerta Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2655643880","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655643880?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:15","pubTimestamp":1785269724,"startTime":"0","endTime":"0","summary":"ImageneBio CFO Yanina Grant-Huerta files initial beneficial ownership statementImageneBio filed a Form 3 reporting Chief Financial Officer Yanina Grant-Huerta as a Section 16 officer as of July 20, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL6KYfqb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653776943","title":"Imagenebio Names Yanina Grant-huerta CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2653776943","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653776943?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:47","pubTimestamp":1784839642,"startTime":"0","endTime":"0","summary":"ImageneBio names Yanina Grant-Huerta CFOImageneBio named Yanina Grant-Huerta chief financial officer, effective July 20, 2026; she had been chief accounting officer at Atara Biotherapeutics.Grant-Huer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL39g9kR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00BJT1NW94.SGD","IBBQ","LU2242646821.SGD","LU2468319806.SGD","PJP","LU1057294990.SGD","PBE","IE00B4R5TH58.HKD","LU0868494617.USD","BBH","IE0002141913.USD","IMA","BK4581","LU0109394709.USD","TBXU","IE00B2B36J28.USD","LU1983299246.USD","BK4534","LU2089984988.USD","LU1571399168.USD","LU2242652126.USD","AMGN","IE00BFTCPJ56.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","BK4139","BK4533","IE0009355771.USD","LU0320765992.SGD","LU1061106388.HKD","LU2112291526.USD","BK4599","LU0058720904.USD","IBB","ATRA","LU0889565916.HKD","BK4588","LU1023059063.AUD","BK4585","BK4007","LU0122379950.USD","LU0289739699.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653831776","title":"Imagenebio - Appoints Yanina Grant-huerta as Chief Financial Officer Effective July 20, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653831776","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653831776?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:27","pubTimestamp":1784838475,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nFWN43P1CD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653247484","title":"Imagenebio Principal Accounting Officer Robert B. Lally Sells USD 17,350 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2653247484","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653247484?lang=en_us&edition=fundamental","pubTime":"2026-07-21 09:47","pubTimestamp":1784598464,"startTime":"0","endTime":"0","summary":"ImageneBio Principal Accounting Officer Robert B. Lally sells USD 17,350 of common sharesImageneBio Principal Accounting Officer Robert B. Lally sold 3,196 common shares on July 16-17.Sales priced at ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL47943:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Imagenebio Principal Accounting Officer Robert B. Lally Sells USD 17,350 of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653245216","title":"Imagenebio Inc Expected to Post a Loss of 89 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2653245216","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653245216?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:31","pubTimestamp":1784579465,"startTime":"0","endTime":"0","summary":"ImageneBio Incexpected to post a loss of89cents a share - Earnings PreviewImageneBio IncIMA.OQIMA.Ois expected to  show no change in quarterly revenue when it reports  results on July 22 (estimated) f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nL8N43M1P3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649938286","title":"ImageneBio appoints Matt Robbins as general counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2649938286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649938286?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:16","pubTimestamp":1783430160,"startTime":"0","endTime":"0","summary":"ImageneBio (IMA) announced the appointment of Matt Robbins as general counsel, effective July 7. Robbins joins the clinical-stage biotechnology com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/imagenebio-appoints-matt-robbins-as-general-counsel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/imagenebio-appoints-matt-robbins-as-general-counsel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","JDOC","XT","AGNG","BBC","FHLC","IMA","RSPH","SYNB","DARP","BBP","BK4588","IBB","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649698438","title":"Imagenebio Names Matt Robbins General Counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2649698438","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649698438?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:01","pubTimestamp":1783422096,"startTime":"0","endTime":"0","summary":"ImageneBio names Matt Robbins general counselImageneBio named Matt Robbins as general counsel, effective July 7, 2026.He will oversee legal, corporate governance, intellectual property, compliance as ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL87sqmx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BCDF","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IMA","BK4588","BK4007","SG9999014005.SGD","SG9999014021.USD","LU0314104364.USD","LU2095319765.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014039.USD","NDAQ","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649981798","title":"Imagenebio Appoints Matt Robbins as General Counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2649981798","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649981798?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:00","pubTimestamp":1783422001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA9DGHJ3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646367012","title":"Imagenebio SVP Finance and Operations Robert Lally Resigns Effective July 22","url":"https://stock-news.laohu8.com/highlight/detail?id=2646367012","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646367012?lang=en_us&edition=fundamental","pubTime":"2026-06-27 04:02","pubTimestamp":1782504158,"startTime":"0","endTime":"0","summary":"ImageneBio SVP Finance and Operations Robert Lally resigns effective July 22ImageneBio announced the resignation of Robert Lally, senior vice president of finance and operations, effective July 22, 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL123Bfx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644294627","title":"ImageneBio stockholders approve amended 2025 equity incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2644294627","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644294627?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:07","pubTimestamp":1781726829,"startTime":"0","endTime":"0","summary":"ImageneBio held its annual shareholder meeting on June 16, 2026.Shareholders backed an amended and restated 2025 Equity Incentive Plan, authorizing 850,000 additional shares for issuance under the plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImageneBio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL3Nz8H0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IMA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":54,"code":"91000000","status":"200"}]}}